• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过将水泡性口炎病毒G蛋白分配到预先形成的囊泡中制备的融合病毒体。

Fusogenic virosomes prepared by partitioning of vesicular stomatitis virus G protein into preformed vesicles.

作者信息

Hug P, Sleight R G

机构信息

Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati College of Medicine, Ohio 45267-0524.

出版信息

J Biol Chem. 1994 Feb 11;269(6):4050-6.

PMID:8307962
Abstract

Virosomes were prepared by the insertion of vesicular stomatitis virus glycoprotein, a pH-sensitive fusion protein, into preformed liposomes. The fusogenic activity of these virosomes was characterized in cell-free fusion assays using liposomal targets. Fusion was monitored by concentration-dependent changes in the efficiency of resonance energy transfer between N-(lissamine rhodamine B sulfonyl)-phosphatidylethanolamine and N-(4-nitrobenzo-2-oxa-1,3-diazol)-phosphatidylethanolamine and by electron microscopy. The fusogenic activity was dependent on the presence of vesicular stomatitis virus glycoprotein, was pH-sensitive, and had a pH threshold of activation similar to that of the native virus. The extent of fusion was dependent upon the lipid composition of the vesicles. This technique will allow vesicles prepared by any method to be made fusogenic.

摘要

通过将水泡性口炎病毒糖蛋白(一种pH敏感的融合蛋白)插入预先形成的脂质体中来制备病毒体。在使用脂质体靶标的无细胞融合试验中对这些病毒体的融合活性进行了表征。通过监测N-(丽丝胺罗丹明B磺酰基)-磷脂酰乙醇胺和N-(4-硝基苯-2-恶唑-1,3-二氮唑)-磷脂酰乙醇胺之间共振能量转移效率的浓度依赖性变化以及通过电子显微镜来监测融合情况。融合活性取决于水泡性口炎病毒糖蛋白的存在,对pH敏感,并且具有与天然病毒相似的激活pH阈值。融合程度取决于囊泡的脂质组成。该技术将使通过任何方法制备的囊泡具有融合性。

相似文献

1
Fusogenic virosomes prepared by partitioning of vesicular stomatitis virus G protein into preformed vesicles.通过将水泡性口炎病毒G蛋白分配到预先形成的囊泡中制备的融合病毒体。
J Biol Chem. 1994 Feb 11;269(6):4050-6.
2
Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G.水泡性口炎病毒糖蛋白G的前融合形式的结构
Science. 2007 Feb 9;315(5813):843-8. doi: 10.1126/science.1135710.
3
Membrane destabilization by N-terminal peptides of viral envelope proteins.病毒包膜蛋白N端肽对膜的去稳定作用。
J Membr Biol. 1992 May;128(1):71-80. doi: 10.1007/BF00231872.
4
Vesicular stomatitis virus glycoprotein mutations that affect membrane fusion activity and abolish virus infectivity.影响膜融合活性并消除病毒感染性的水疱性口炎病毒糖蛋白突变。
J Virol. 1995 Mar;69(3):1435-43. doi: 10.1128/JVI.69.3.1435-1443.1995.
5
Solubilization and reconstitution of vesicular stomatitis virus envelope using octylglucoside.使用辛基葡糖苷对水疱性口炎病毒包膜进行增溶和复性。
Biophys J. 1997 Apr;72(4):1683-94. doi: 10.1016/S0006-3495(97)78814-3.
6
Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G.水泡性口炎病毒糖蛋白G低pH值形式的晶体结构。
Science. 2006 Jul 14;313(5784):187-91. doi: 10.1126/science.1127683.
7
pH-dependent fusion induced by vesicular stomatitis virus glycoprotein reconstituted into phospholipid vesicles.水泡性口炎病毒糖蛋白重组到磷脂囊泡中诱导的pH依赖性融合。
J Biol Chem. 1984 Apr 10;259(7):4622-8.
8
Mutational analysis of the vesicular stomatitis virus glycoprotein G for membrane fusion domains.水泡性口炎病毒糖蛋白G膜融合结构域的突变分析
J Virol. 1993 Jul;67(7):4070-7. doi: 10.1128/JVI.67.7.4070-4077.1993.
9
Preparation of virosomes coated with the vesicular stomatitis virus glycoprotein as efficient gene transfer vehicles for animal cells.制备包被有水泡性口炎病毒糖蛋白的病毒体作为动物细胞高效基因转移载体。
Microbiol Immunol. 2004;48(3):163-74. doi: 10.1111/j.1348-0421.2004.tb03502.x.
10
Influence of membrane anchoring and cytoplasmic domains on the fusogenic activity of vesicular stomatitis virus glycoprotein G.膜锚定结构域和细胞质结构域对水疱性口炎病毒糖蛋白G融合活性的影响。
J Virol. 1997 Oct;71(10):7996-8000. doi: 10.1128/JVI.71.10.7996-8000.1997.

引用本文的文献

1
Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical Challenges.基于纳米平台的鼻腔内疫苗:当前进展和临床挑战。
ACS Nano. 2024 Sep 10;18(36):24650-24681. doi: 10.1021/acsnano.3c10797. Epub 2024 Aug 26.
2
Virosome: An engineered virus for vaccine delivery.病毒体:一种用于疫苗递送的工程病毒。
Saudi Pharm J. 2023 May;31(5):752-764. doi: 10.1016/j.jsps.2023.03.016. Epub 2023 Mar 31.
3
Rhabdoviruses as vectors for vaccines and therapeutics.Rhabdoviruses 作为疫苗和治疗药物的载体。
Curr Opin Virol. 2020 Oct;44:169-182. doi: 10.1016/j.coviro.2020.09.003. Epub 2020 Oct 29.
4
In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein.通过添加水泡性口炎病毒替代包膜G蛋白,将无感染性的莫洛尼逆转录病毒颗粒在体外无细胞条件下转化为感染性形式。
J Virol. 1998 Aug;72(8):6356-61. doi: 10.1128/JVI.72.8.6356-6361.1998.
5
Enhanced gene transfer with fusogenic liposomes containing vesicular stomatitis virus G glycoprotein.含有水泡性口炎病毒G糖蛋白的融合脂质体增强基因转移。
J Virol. 1998 Jul;72(7):6159-63. doi: 10.1128/JVI.72.7.6159-6163.1998.
6
Interaction of the influenza hemagglutinin fusion peptide with lipid bilayers: area expansion and permeation.流感血凝素融合肽与脂质双层的相互作用:面积扩展与渗透。
Biophys J. 1997 Sep;73(3):1430-9. doi: 10.1016/S0006-3495(97)78175-X.
7
Solubilization and reconstitution of vesicular stomatitis virus envelope using octylglucoside.使用辛基葡糖苷对水疱性口炎病毒包膜进行增溶和复性。
Biophys J. 1997 Apr;72(4):1683-94. doi: 10.1016/S0006-3495(97)78814-3.